Page last updated: 2024-10-20

trimethylamine and Alzheimer Disease

trimethylamine has been researched along with Alzheimer Disease in 1 studies

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research Excerpts

ExcerptRelevanceReference
"Alzheimer's disease is associated with multiple risk factors and is the most common type of dementia."2.82The role of trimethylamine-N-Oxide in the development of Alzheimer's disease. ( Buawangpong, N; Chattipakorn, N; Chattipakorn, SC; Pinyopornpanish, K; Siri-Angkul, N, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Buawangpong, N1
Pinyopornpanish, K1
Siri-Angkul, N1
Chattipakorn, N1
Chattipakorn, SC1

Reviews

1 review available for trimethylamine and Alzheimer Disease

ArticleYear
The role of trimethylamine-N-Oxide in the development of Alzheimer's disease.
    Journal of cellular physiology, 2022, Volume: 237, Issue:3

    Topics: Alzheimer Disease; Animals; Choline; Methylamines; Oxides

2022